Isotopen Technologien München

Living Theranostics ITG Isotope Technologies Garching GmbH is a highly specialized radiopharmaceutical company and was founded in 2007 as

ITM Isotopen Technologien München AG and its subsidiaries ITG GmbH and RP München GmbH provide an advanced theranostic platform covering all aspects of innovative radiopharmaceutical technologies. We have systematically and sustainably established ourselves on all levels of the radiopharmaceutical value chain and have an unprecedented knowledge with regards to radiopharmaceutical development and integrated supply chain solutions. We take pride in being recognized as THE PLATFORM in radioisotope research and development. This confidence strengthens our commitment to striving for excellence in further developing innovative, integrated, highly effective next generation targeted radioisotope treatments. We endeavour to stick to this path - doing so, we are capable to master future challenges successfully. We feel confident that our contribution to society and your health in particular marks a major step forward in changing medicine for the better. It is therefore our commitment to continuously bring most modern products to our patients around the world and establish ourselves as the key driver of radionuclide theranostics.